Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
56,047,431
-
Number of holders
-
217
-
Total 13F shares, excl. options
-
54,377,224
-
Shares change
-
+154,088
-
Total reported value, excl. options
-
$1,451,012,413
-
Value change
-
+$2,475,554
-
Put/Call ratio
-
12%
-
Number of buys
-
105
-
Number of sells
-
103
-
Price
-
$26.67
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) as of Q3 2021
As of 30 Sep 2021 SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) had 265 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 54,377,224 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, ARMISTICE CAPITAL, LLC, DIMENSIONAL FUND ADVISORS LP, MACQUARIE GROUP LTD, STATE STREET CORP, LOOMIS SAYLES & CO L P, GW&K Investment Management, LLC, RENAISSANCE TECHNOLOGIES LLC, and Aristotle Capital Boston, LLC.
This table shows 265 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.